首页 | 本学科首页   官方微博 | 高级检索  
     

美罗培南治疗新生儿及婴幼儿重症感染疗效评价
引用本文:刘宇,米弘英,杨芬. 美罗培南治疗新生儿及婴幼儿重症感染疗效评价[J]. 中国药房, 2011, 0(26): 2466-2468
作者姓名:刘宇  米弘英  杨芬
作者单位:昆明医学院附属昆华医院;云南省第一人民医院;大理学院药学院;
摘    要:
目的:评价美罗培南治疗新生儿及婴幼儿重症感染的疗效及安全性。方法:回顾性分析98例患儿应用美罗培南治疗的疗效,每次给药剂量为15mg·kg-1,q8h,静脉滴注,平均疗程10d,并对疗效、细菌学和不良反应进行评价。结果:美罗培南治疗患儿重症感染有效率94.90%(93/98),痊愈率85.71%(84/98),细菌清除率84.31%(43/51),不良反应发生率6.12%(6/98)。结论:美罗培南治疗新生儿及婴幼儿重症感染疗效显著、安全性好。

关 键 词:美罗培南  新生儿  婴幼儿  重症感染

Efficacy Evaluation of Meropenem in the Treatment of Severe Infection in New-born and Infant
LIU Yu,MI Hong-yingYANG Fen. Efficacy Evaluation of Meropenem in the Treatment of Severe Infection in New-born and Infant[J]. China Pharmacy, 2011, 0(26): 2466-2468
Authors:LIU Yu  MI Hong-yingYANG Fen
Affiliation:LIU Yu,MI Hong-ying(Kunhua Hospital Affiliated to Kunming Medical University/Yunnan Provincial First People’s Hospital, Kunming 650032, China)YANG Fen(School of Pharmacy, Dali University, Dali 671000, China)
Abstract:
OBJECTIVE:To evaluate the therapeutic efficacy and safety of meropenem in the treatment of severe infections in new-born and infants. METHODS:The therapeutic efficacies of meropenem in 98 cases of severe infections were analyzed retrospectively. They were treated with meropenem by way of intravenous drip with a dose of 15 mg·kg-1 each time, q8 h, with an average of 10 days in one course. The therapeutic efficacy, bacteriology and adverse drug reaction were evaluated. RESULTS:The effective rate, cure rate, bacterial clearance rate and the incidence of drug adverse reaction of meropenem therapy for pediatric severe infection were 94.90%(93/98), 85.71%(84/98), 84.31%(43/51), 6.12%(6/98), respectively. CONCLUSION:Meropenem is effective and safe for the treatment of newborn and infants with severe infections.
Keywords:Meropenem  New-born  Infants  Severe infection  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号